These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9645388)
1. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. Shabani F; McNeil J; Tippett L Free Radic Res; 1998 Feb; 28(2):115-23. PubMed ID: 9645388 [TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. Wang Y; Rosen H; Madtes DK; Shao B; Martin TR; Heinecke JW; Fu X J Biol Chem; 2007 Nov; 282(44):31826-34. PubMed ID: 17726014 [TBL] [Abstract][Full Text] [Related]
3. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. Fu X; Kassim SY; Parks WC; Heinecke JW J Biol Chem; 2003 Aug; 278(31):28403-9. PubMed ID: 12759346 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of collagenase activity by N-chlorotaurine, a product of activated neutrophils. Davies JM; Horwitz DA; Davies KJ Arthritis Rheum; 1994 Mar; 37(3):424-7. PubMed ID: 8129798 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Moreau M; Brocheriou I; Petit L; Ninio E; Chapman MJ; Rouis M Circulation; 1999 Jan; 99(3):420-6. PubMed ID: 9918530 [TBL] [Abstract][Full Text] [Related]
7. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
8. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791 [TBL] [Abstract][Full Text] [Related]
9. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Sadowski T; Steinmeyer J Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1. Iyer S; Wei S; Brew K; Acharya KR J Biol Chem; 2007 Jan; 282(1):364-71. PubMed ID: 17050530 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of protease inhibitors and lysozyme by hypochlorous acid: role of side-chain oxidation and protein unfolding in loss of biological function. Hawkins CL; Davies MJ Chem Res Toxicol; 2005 Oct; 18(10):1600-10. PubMed ID: 16533025 [TBL] [Abstract][Full Text] [Related]
12. Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Peskin AV; Winterbourn CC Free Radic Biol Med; 2006 Jan; 40(1):45-53. PubMed ID: 16337878 [TBL] [Abstract][Full Text] [Related]
13. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures. Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145 [TBL] [Abstract][Full Text] [Related]
14. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456 [TBL] [Abstract][Full Text] [Related]
16. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230 [TBL] [Abstract][Full Text] [Related]
17. IkappaB is a sensitive target for oxidation by cell-permeable chloramines: inhibition of NF-kappaB activity by glycine chloramine through methionine oxidation. Midwinter RG; Cheah FC; Moskovitz J; Vissers MC; Winterbourn CC Biochem J; 2006 May; 396(1):71-8. PubMed ID: 16405428 [TBL] [Abstract][Full Text] [Related]
18. Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Davies JM; Horwitz DA; Davies KJ Free Radic Biol Med; 1993 Dec; 15(6):637-43. PubMed ID: 8138190 [TBL] [Abstract][Full Text] [Related]
19. Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase. Kleine T; Bartsch S; Bläser J; Schnierer S; Triebel S; Valentin M; Gote T; Tschesche H Biochemistry; 1993 Dec; 32(51):14125-31. PubMed ID: 8260495 [TBL] [Abstract][Full Text] [Related]
20. Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs. Wasil M; Halliwell B; Moorhouse CP; Hutchison DC; Baum H Biochem Pharmacol; 1987 Nov; 36(22):3847-50. PubMed ID: 2825705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]